{"id":2223,"date":"2022-09-01T00:00:00","date_gmt":"2022-09-01T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2223"},"modified":"2022-09-01T00:00:00","modified_gmt":"2022-09-01T00:00:00","slug":"a-centogene-fara-apresentacoes-em-conferencias-de-parcerias-com-investidores-que-acontecerao-em-setembro","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/pt\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\/","title":{"rendered":"A CENTOGENE far\u00e1 apresenta\u00e7\u00f5es nas pr\u00f3ximas confer\u00eancias para investidores e parceiros em setembro."},"content":{"rendered":"<p><strong>CAMBRIDGE, Massachusetts, ROSTOCK, Alemanha e BERLIM, 1\u00ba de setembro de 2022 (GLOBE NEWSWIRE)<\/strong> \u2013 A Centogene NV (Nasdaq: CNTG), parceira essencial em biodados para o setor de ci\u00eancias da vida em est\u00e1gio comercial, voltada para doen\u00e7as raras e neurodegenerativas, anunciou hoje sua programa\u00e7\u00e3o de confer\u00eancias sobre investimentos e parcerias para setembro de 2022. A administra\u00e7\u00e3o da empresa far\u00e1 uma apresenta\u00e7\u00e3o na HC Wainwright 24.<sup>o<\/sup> Confer\u00eancia Anual de Investimento Global em Nova Iorque e a 9\u00aa<sup>o<\/sup> O F\u00f3rum Anual de Investimento em HealthTech (HTIF) faz parte da Semana de Ci\u00eancias da Vida de Outono da Sachs em Basileia. A CENTOGENE convida investidores e parceiros a assistirem \u00e0s apresenta\u00e7\u00f5es e a agendarem reuni\u00f5es individuais.<\/p>\n<p>Veja mais detalhes abaixo:<\/p>\n<h2>HC Wainwright 24<sup>o<\/sup> Confer\u00eancia Anual de Investimento Global<\/h2>\n<p><strong>Apresenta\u00e7\u00e3o: <\/strong>12 de setembro de 2022, \u00e0s 9h30 EDT (15h30 CEST)<br \/> <strong>Localiza\u00e7\u00e3o:<\/strong> Hotel Lotte New York Palace, Nova Iorque \/ Virtual<br \/> <strong>Palestrante:<\/strong> Kim Stratton \u2013 CEO da Centogene NV.<br \/> <strong>Formatar:<\/strong> Apresenta\u00e7\u00e3o da empresa e reuni\u00f5es individuais<br \/> <strong>Transmiss\u00e3o online:<\/strong> <a href=\"https:\/\/journey.ct.events\/view\/5ab7d864-0de2-4370-a47f-7b5436705b5a\" target=\"_blank\" title=\"Transmiss\u00e3o online da 24\u00aa Confer\u00eancia Anual de Investimentos Globais da HC Wainwright\">https:\/\/journey.ct.events\/view\/5ab7d864-0de2-4370-a47f-7b5436705b5a<\/a><\/p>\n<p class=\"t3m-small\"><sup>*<\/sup>Uma grava\u00e7\u00e3o da apresenta\u00e7\u00e3o estar\u00e1 dispon\u00edvel durante 90 dias ap\u00f3s a sua conclus\u00e3o.<\/p>\n<p>Entre em contato com seu representante na HC Wainwright para agendar uma reuni\u00e3o virtual individual com a CENTOGENE durante a confer\u00eancia. Para obter informa\u00e7\u00f5es sobre a Confer\u00eancia Global de Investimentos da HC Wainwright, consulte o site do evento (<a href=\"https:\/\/hcwevents.com\/annualconference\/\" target=\"_blank\" title=\"Site do evento\">https:\/\/hcwevents.com\/annualconference\/<\/a>).&nbsp;<\/p>\n<h2>9<sup>o<\/sup> F\u00f3rum Anual de Investimento em Tecnologia da Sa\u00fade<\/h2>\n<p><strong>Data:<\/strong> 20 de setembro de 2022<br \/> <strong>Localiza\u00e7\u00e3o:<\/strong> Hotel M\u00f6venpick Basel, Su\u00ed\u00e7a<br \/> <strong>Palestrante:<\/strong> Kim Stratton \u2013 CEO da Centogene NV.<br \/> <strong>Formatar:<\/strong> Apresenta\u00e7\u00e3o da empresa, painel de discuss\u00e3o e reuni\u00f5es individuais.<\/p>\n<p>Para obter informa\u00e7\u00f5es sobre o 9<sup>o<\/sup> F\u00f3rum Anual de Investimento em HealthTech, consulte o site do evento (<a href=\"https:\/\/www.sachsforum.com\/9htif-about.html\" target=\"_blank\" title=\"Site do evento\">https:\/\/www.sachsforum.com\/9htif-about.html<\/a>A equipe de Desenvolvimento de Neg\u00f3cios da CENTOGENE pode ser contatada diretamente pelo endere\u00e7o de e-mail fornecido. <a href=\"mailto:BD@centogene.com\" title=\"Entre em contato com a equipe de Desenvolvimento de Neg\u00f3cios da CENTOGENE.\">BD(at)centogene(dot)com<\/a> Para agendar reuni\u00f5es.<\/p>\n<h3>Sobre a CENTOGENE<\/h3>\n<p>A CENTOGENE (Nasdaq: CNTG) est\u00e1 transformando dados cl\u00ednicos, gen\u00e9ticos e multi\u00f4micos do mundo real para possibilitar melhores resultados de sa\u00fade para pacientes com doen\u00e7as raras e neurodegenerativas. H\u00e1 mais de 15 anos, a CENTOGENE fornece informa\u00e7\u00f5es diagn\u00f3sticas para pacientes com doen\u00e7as gen\u00e9ticas por meio de nossa rede de quase 30.000 m\u00e9dicos ativos. A CENTOGENE acredita que seu Biobanco de Dados \u00e9 o maior reposit\u00f3rio de dados do mundo, contendo informa\u00e7\u00f5es de pacientes de mais de 120 pa\u00edses. Solu\u00e7\u00f5es log\u00edsticas simplificadas, incluindo o CentoCard\u00ae para envio de amostras biol\u00f3gicas, e nossos laborat\u00f3rios de refer\u00eancia multi\u00f4micos de \u00faltima gera\u00e7\u00e3o, certificados pelas normas ISO, CAP e CLIA, oferecem aos pacientes diagn\u00f3sticos r\u00e1pidos e confi\u00e1veis para apoiar a identifica\u00e7\u00e3o e a personaliza\u00e7\u00e3o de seus tratamentos. Em \u00faltima an\u00e1lise, oferecer o melhor tratamento para os pacientes envolve o desenvolvimento de terapias novas ou melhores. Estamos reduzindo os riscos da descoberta e do desenvolvimento de medicamentos \u00f3rf\u00e3os por meio de parcerias com mais de 30 empresas biofarmac\u00eauticas em triagem de alvos e medicamentos, desenvolvimento cl\u00ednico, acesso ao mercado e expans\u00e3o. A CENTOGENE estabelece parcerias de biodados por meio de nossas Licen\u00e7as de Biodados e Relat\u00f3rios de An\u00e1lise.<\/p>\n<p>Para saber mais sobre nossos produtos, projetos em desenvolvimento e prop\u00f3sito centrado no paciente, visite [link]. <a href=\"https:\/\/www.centogene.com\/pt\/\" title=\"Site da CENTOGENE\">www.centogene.com<\/a> e siga-nos em <a href=\"https:\/\/de.linkedin.com\/company\/centogene\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>.<\/p>\n<h3>Declara\u00e7\u00f5es prospectivas<\/h3>\n<p>Este comunicado de imprensa cont\u00e9m &quot;declara\u00e7\u00f5es prospectivas&quot; conforme definido pelas leis federais de valores mobili\u00e1rios dos EUA. Declara\u00e7\u00f5es aqui contidas que n\u00e3o sejam claramente de natureza hist\u00f3rica s\u00e3o prospectivas, e palavras como &quot;antecipar&quot;, &quot;acreditar&quot;, &quot;continuar&quot;, &quot;esperar&quot;, &quot;estimar&quot;, &quot;pretender&quot;, &quot;projetar&quot; e express\u00f5es semelhantes, bem como verbos no futuro ou no condicional, como &quot;ir\u00e1&quot;, &quot;poderia&quot;, &quot;deveria&quot;, &quot;conseguiria&quot;, &quot;talvez&quot;, &quot;pode&quot; e &quot;pode&quot;, geralmente s\u00e3o utilizadas para identificar declara\u00e7\u00f5es prospectivas. Tais declara\u00e7\u00f5es prospectivas envolvem riscos conhecidos e desconhecidos, incertezas e outros fatores importantes que podem fazer com que os resultados, o desempenho ou as conquistas reais da CENTOGENE sejam materialmente diferentes de quaisquer resultados, desempenho ou conquistas futuros expressos ou impl\u00edcitos nas declara\u00e7\u00f5es prospectivas. Tais riscos e incertezas incluem, entre outros, condi\u00e7\u00f5es econ\u00f4micas e geopol\u00edticas negativas, instabilidade e volatilidade nos mercados financeiros mundiais, poss\u00edveis mudan\u00e7as na legisla\u00e7\u00e3o, regulamenta\u00e7\u00e3o e pol\u00edticas governamentais atuais e propostas, press\u00f5es decorrentes do aumento da concorr\u00eancia e consolida\u00e7\u00e3o em nosso setor, o custo e a incerteza da aprova\u00e7\u00e3o regulat\u00f3ria, inclusive da Food and Drug Administration (FDA) dos EUA, nossa depend\u00eancia de terceiros e parceiros de colabora\u00e7\u00e3o, incluindo nossa capacidade de gerenciar o crescimento e estabelecer novos relacionamentos com clientes, nossa depend\u00eancia do setor de doen\u00e7as raras, nossa capacidade de gerenciar a expans\u00e3o internacional, nossa depend\u00eancia de pessoal-chave, nossa depend\u00eancia da prote\u00e7\u00e3o da propriedade intelectual, flutua\u00e7\u00f5es em nossos resultados operacionais devido ao efeito das taxas de c\u00e2mbio, nossa capacidade de otimizar o uso do caixa, nossa necessidade de financiamento adicional ou outros fatores. Para obter mais informa\u00e7\u00f5es sobre os riscos e incertezas que podem fazer com que os resultados reais sejam diferentes daqueles expressos nessas declara\u00e7\u00f5es prospectivas, bem como sobre os riscos relacionados aos neg\u00f3cios da CENTOGENE em geral, consulte os fatores de risco da CENTOGENE descritos no Formul\u00e1rio 20-F da CENTOGENE, arquivado em 31 de mar\u00e7o de 2022 junto \u00e0 Comiss\u00e3o de Valores Mobili\u00e1rios dos EUA (a \u201cSEC\u201d), e em arquivamentos subsequentes junto \u00e0 SEC. Quaisquer declara\u00e7\u00f5es prospectivas contidas neste comunicado \u00e0 imprensa referem-se apenas \u00e0 data deste documento, e a CENTOGENE se isenta especificamente de qualquer obriga\u00e7\u00e3o de atualizar qualquer declara\u00e7\u00e3o prospectiva, seja como resultado de novas informa\u00e7\u00f5es, eventos futuros ou outros fatores.<\/p>\n<h5>Contato com a m\u00eddia: &nbsp;<\/h5>\n<p>CENTOGENE<\/p>\n<p>Lennart Streibel<br \/> Rela\u00e7\u00f5es com Investidores<br \/> <a href=\"mailto:investor.relations@centogene.com\" title=\"Escreva um e-mail\">investor.relations(at)centogene(dot)com&nbsp;<\/a><\/p>\n<p>Ben Legg<br \/> Comunica\u00e7\u00e3o Corporativa&nbsp;<br \/> <a href=\"mailto:press@centogene.com\" title=\"Escreva um e-mail\">press(at)centogene(dot)com<\/a><\/p>\n<p>Stern IR &nbsp;<br \/> Suzanne Messere<br \/> +1 (212) 698-8801<br \/> <a href=\"mailto:suzanne.messere@sternir.com\">suzanne.messere(at)sterni(ponto)com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>A Centogene NV (Nasdaq: CNTG), parceira essencial em biodados para o setor de ci\u00eancias da vida em est\u00e1gio comercial, voltada para doen\u00e7as raras e neurodegenerativas, anunciou hoje sua programa\u00e7\u00e3o de confer\u00eancias sobre investimentos e parcerias para setembro de 2022.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2223","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE to Present at Upcoming Investor &amp; Partnering Conferences in September | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/pt\/a-centogene-fara-apresentacoes-em-conferencias-de-parcerias-com-investidores-que-acontecerao-em-setembro\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE to Present at Upcoming Investor &amp; Partnering Conferences in September | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its investment and partnering conference schedule for September 2022.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/pt\/a-centogene-fara-apresentacoes-em-conferencias-de-parcerias-com-investidores-que-acontecerao-em-setembro\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-01T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE to Present at Upcoming Investor &#038; Partnering Conferences in September\",\"datePublished\":\"2022-09-01T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\\\/\"},\"wordCount\":814,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\\\/\",\"name\":\"CENTOGENE to Present at Upcoming Investor & Partnering Conferences in September | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2022-09-01T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE to Present at Upcoming Investor &#038; Partnering Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/pt\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A CENTOGENE apresentar\u00e1 em confer\u00eancias de investidores e parceiros em setembro | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/pt\/a-centogene-fara-apresentacoes-em-conferencias-de-parcerias-com-investidores-que-acontecerao-em-setembro\/","og_locale":"pt_BR","og_type":"article","og_title":"CENTOGENE to Present at Upcoming Investor & Partnering Conferences in September | CENTOGENE","og_description":"Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its investment and partnering conference schedule for September 2022.","og_url":"https:\/\/www.centogene.com\/pt\/a-centogene-fara-apresentacoes-em-conferencias-de-parcerias-com-investidores-que-acontecerao-em-setembro\/","og_site_name":"CENTOGENE","article_published_time":"2022-09-01T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admincg","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE to Present at Upcoming Investor &#038; Partnering Conferences in September","datePublished":"2022-09-01T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\/"},"wordCount":814,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\/","url":"https:\/\/www.centogene.com\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\/","name":"A CENTOGENE apresentar\u00e1 em confer\u00eancias de investidores e parceiros em setembro | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2022-09-01T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-to-present-at-upcoming-investor-partnering-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE to Present at Upcoming Investor &#038; Partnering Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Orientando a Medicina de Precis\u00e3o","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"admincg","url":"https:\/\/www.centogene.com\/pt\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/posts\/2223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/comments?post=2223"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/posts\/2223\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/media?parent=2223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/categories?post=2223"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/tags?post=2223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}